PSIP1 and diabetes mellitus: The relatively low frequency of anti-DFS70/LEDGFp75 autoantibodies in the disease groups that we tested by the different assay platforms (1.4% in DM, 4.3% in RA) is consistent with previous frequencies reported in the literature for rheumatic diseases [4, 8].